Significant Ownership of Deep Track Capital, LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Deep Track Capital, LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ David Kroin - David Kroin, Managing Member of the General Partner of the Investment Adviser
Manager location
Greenwich, CT

Follow Filing Activity

Follow Deep Track Capital, LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Deep Track Capital, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share 15% 3,352,804 Deep Track Capital, LP 12 Sep 2025
VSTM Verastem, Inc. Common stock, $0.0001 par value per share 10% $60,288,436 7,719,390 Deep Track Capital, LP 14 Nov 2025
ALT Altimmune, Inc. Common stock, par value $0.0001 per share 10% $59,805,041 19,417,221 Deep Track Capital, LP 23 Apr 2026
CMPS COMPASS Pathways plc American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share 10% $34,965,201 9,274,589 Deep Track Capital, LP 10 Jan 2025
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 10% $6,137,415 902,561 Deep Track Capital, LP 30 Jan 2026
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 10% $4,568,300 2,366,995 Deep Track Capital, LP 12 Aug 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 9.9% $12,280,920 14,116,000 Deep Track Capital, LP 23 Dec 2024
OCUL Ocular Therapeutix, Inc Common Stock, $0.0001 par value per share 9.5% $184,731,000 +$85,196,590 20,850,000 +86% Deep Track Capital, LP 31 Mar 2026
MAZE Maze Therapeutics Inc. Common Stock, $0.001 par value per share 9% $59,431,096 +$13,927,661 3,948,910 +31% Deep Track Capital, LP 30 Jun 2025
IMUX Immunic, Inc. Common Stock, $0.0001 par value 8.7% $9,964,980 11,454,000 Deep Track Capital, LP 17 Feb 2026
TARS Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 8.5% $261,540,000 +$43,590,000 3,600,000 +20% Deep Track Capital, LP 31 Mar 2026
CNTX Context Therapeutics Inc. Common Stock, $0.001 par value per share 8.3% $7,419,355 7,419,355 Deep Track Capital, LP 31 Mar 2025
CRMD CorMedix Inc. Common stock, $0.001 par value 7.9% $44,985,125 +$9,454,283 6,274,076 +27% Deep Track Capital, LP 31 Mar 2026
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.3% $12,137,760 13,486,400 Deep Track Capital, LP 08 Jan 2026
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 7% $33,735,450 9,345,000 Deep Track Capital, LP 09 Mar 2026
MNMD Mind Medicine (MindMed) Inc. Common Shares 6.9% $64,845,000 -$11,790,000 5,500,000 -15% Deep Track Capital, LP 30 Sep 2025
ENTA ENANTA PHARMACEUTICALS INC Common Stock, par value $0.01 per share 6.8% $25,263,153 +$6,098,090 1,956,867 +32% Deep Track Capital, LP 31 Dec 2025
ENGN enGene Holdings Inc. Common Shares 6.7% $30,048,631 +$14,462,734 4,317,332 +93% Deep Track Capital, LP 11 Nov 2025
MBX MBX Biosciences, Inc. Common Stock, $0.0001 par value per share 6.6% $28,604,897 2,188,592 Deep Track Capital, LP 30 Jun 2025
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 6.5% $33,054,209 4,610,071 Deep Track Capital, LP 05 Nov 2025
BCAX Bicara Therapeutics Inc. Common Stock, $0.0001 par value 6.2% $89,943,750 +$29,058,750 4,062,500 +48% Deep Track Capital, LP 31 Mar 2026
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 6.2% $98,414,734 +$13,109,734 6,345,244 +15% Deep Track Capital, LP 31 Mar 2026
ALMS ALUMIS INC. Common Stock, $0.0001 par value per share 6% $162,185,631 7,362,035 Deep Track Capital, LP 30 Mar 2026
GPCR Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value 6% $855,579,599 -$21,646,354 12,335,346 -2.5% Deep Track Capital, LP 31 Dec 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 par value 5.8% $60,642,286 +$60,642,286 3,055,027 Deep Track Capital, LP 22 May 2026
IMVT Immunovant Inc. Common Stock, $0.0001 par value per share 5.6% $144,590,000 9,500,000 Deep Track Capital, LP 19 Mar 2025
PSNL Personalis, Inc. Common Stock, $0.0001 par value per share 5.5% $36,349,556 5,760,627 Deep Track Capital, LP 05 May 2026
VERA Vera Therapeutics, Inc. Class A common stock, $0.001 par value per share 5.5% $176,892,640 3,921,362 Deep Track Capital, LP 04 Mar 2026
VRDN VIRIDIAN THERAPEUTICS, INC. Common Stock, $0.01 par value per share 5.3% $75,305,474 +$40,210,295 5,417,660 +115% Deep Track Capital, LP 01 May 2026
GERN Geron Corp Common Stock, $0.001 par value 5% $55,510,486 -$1,384,238 31,720,278 -2.4% Deep Track Capital, LP 31 Mar 2026
ABVX Abivax SA Ordinary Shares (represented by American Depository Shares) 4.8% $28,885,195 3,480,144 Deep Track Capital, LP 30 Jun 2025
HELP CYBIN INC. Common Shares, no par value 4.7% $18,486,334 -$5,262,159 2,391,505 -22% Deep Track Capital, LP 31 Dec 2025
SWTX Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $160,025,357 3,460,756 Deep Track Capital, LP 31 Dec 2024
ORKA Oruka Therapeutics, Inc. Common stock, $0.001 Par Value 4.5% $65,515,368 +$8,023,966 2,161,510 +14% Deep Track Capital, LP 31 Dec 2025
GH Guardant Health, Inc. Common Stock, $0.00001 Par Value 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
OKUR Onkure Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.1% $1,330,932 523,989 Deep Track Capital, LP 31 Dec 2024
IVA Inventiva S.A. Ordinary shares, nominal value 0.01 EUR per share 3.8% $42,902,558 -$21,276,849 7,800,465 -33% Deep Track Capital, LP 31 Mar 2026
APLS Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 3.6% $184,422,298 -$100,407,702 4,532,374 -35% Deep Track Capital, LP 31 Mar 2026
DFTX Definium Therapeutics, Inc. Common Shares 3% $66,750,000 -$59,553,015 3,000,000 -47% Deep Track Capital, LP 31 Mar 2026
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 3% $111,762,000 -$154,160,600 3,150,000 -58% Deep Track Capital, LP 31 Dec 2025
KRRO Korro Bio, Inc. Common stock, par value $0.001 per share 3% $3,638,575 277,966 Deep Track Capital, LP 30 Jun 2025
PTGX Protagonist Therapeutics, Inc Common Stock, par value $0.00001 2.8% $113,973,353 -$101,924,147 1,715,691 -47% Deep Track Capital, LP 30 Sep 2025
BCYC Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share 2.4% $9,625,952 -$12,943,416 1,203,244 -57% Deep Track Capital, LP 30 Jun 2025
INO INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value 2.4% $3,076,623 1,314,796 Deep Track Capital, LP 30 Sep 2025
FDMT 4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share 1.3% $1,982,175 609,900 Deep Track Capital, LP 31 Dec 2024
NKTR Nektar Therapeutics Common Stock, par value $0.0001 1.1% $1,462,239 1,975,998 Deep Track Capital, LP 31 Dec 2024
AUTL Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share 0.97% $4,186,839 2,568,613 Deep Track Capital, LP 30 Sep 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 0.4% $3,713,262 110,448 Deep Track Capital, LP 31 Dec 2025
ZURA Zura Bio Ltd Class A Ordinary Shares, $0.0001 par value 0.4% $1,121,531 -$18,867,975 259,014 -94% Deep Track Capital, LP 30 Sep 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$5,842,754 0 -100% Deep Track Capital, LP 30 Sep 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 0 Deep Track Capital, LP 31 Dec 2024
IMA IMAGENEBIO, INC. Common Stock, $0.001 par value 0% $0 -$5,938,768 0 -100% Deep Track Capital, LP 31 Dec 2025
DNTH Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value 0% $0 -$92,775,574 0 -100% Deep Track Capital, LP 30 Sep 2025
DVAX Dynavax Technologies Corporation Common Stock, $0.001 par value 0% $0 -$247,218,206 0 -100% Deep Track Capital, LP 10 Feb 2026
TECX Tectonic Therapeutic, Inc. Common Stock $0.0001 par value per share 0% $0 -$21,996,407 0 -100% Deep Track Capital, LP 30 Sep 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 0% $0 -$19,224,879 0 -100% Deep Track Capital, LP 31 Dec 2025
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 -$99,119,162 0 -100% Deep Track Capital, LP 31 Dec 2025
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 -$2,386,791 0 -100% Deep Track Capital, LP 30 Jun 2025
IVVD Invivyd, Inc. Common stock, par value $0.0001 per share 0% $0 -$10,694,479 0 -100% Deep Track Capital, LP 30 Sep 2025
AKRO Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$178,786,520 0 -100% Deep Track Capital, LP 31 Dec 2025
JBIO Jade Biosciences, Inc. Common Stock, $0.0001 par value per share 0% $0 -$31,599,303 0 -100% Deep Track Capital, LP 31 Dec 2025
ETNB 89bio, Inc. Common stock, par value $0.001 per share 0% $0 -$126,886,520 0 -100% Deep Track Capital, LP 31 Dec 2025
IKNA Ikena Oncology, Inc. Common Stock, $0.001 par value 0% $0 -$2,666,444 0 -100% Deep Track Capital, LP 28 Jul 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP 30 Jun 2025
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP 31 Dec 2024
EDIT Editas Medicine, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Deep Track Capital, LP 31 Dec 2024

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .